First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark COPENHAGEN, DENMARK—21 January 2025 — CSL Behring Denmark today announced that the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback